Bijaya Sharma

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 384 citations · Full text

Medicine, Cancer Biology, Oncology +17

Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells

Bijaya Sharma, Autumn V. Brown, Nicole E. Matluck et al. · Antimicrobial Agents and Chemotherapy · 2015 · 186 citations · Full text

Veterinary Medicine, Infectious Diseases, Host-pathogen Interactions +7

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition

Joao V. Alessi, Biagio Ricciuti, Liam F. Spurr et al. · Journal of Thoracic Oncology · 2021 · 149 citations

Medicine, Molecular Genetics, Oncology +14

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief et al. · Annals of Oncology · 2022 · 101 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer

Joao V. Alessi, Biagio Ricciuti, Stephanie Alden et al. · Journal for ImmunoTherapy of Cancer · 2021 · 98 citations · Full text

Medicine, Immunology, Oncology +17